Acon and Humus Capital in pharma acquisition
LATIN LAWYER
Beccar Varela has helped private equity firm Acon and Argentine counterpart Humus Capital acquire a majority interest in biotechnology company Biosidus. Biosidus relied on M & M Bomchil.
It is also thought to have hired Estudio Rosso Alba, Francia & Asociados, but the firm did not confirm this
information prior to publishing. The deal closed on 5 June.
Acon specialises in US and Latin American investments, while Humus Capital focuses on middle market,
emerging growth and growth capital spends. Both companies have said they plan to continue Biosidus’
international expansion.
Biosidus is Argentina’s largest manufacturer and distributor of biosimilar pharmaceuticals and exports to
more than 25 countries worldwide.
Counsel to ACON Bios Investors and Humus Capital Partners
Beccar Varela
Partners Tomás Allende and Santiago Montezanti, and associates Pedro Silvestri, Ana Andrés, Lucía Guardone, Juan Francisco Oria and Elizabeth Haag.
Seguir leyendo:
latinlawyer_biosidus.pdf
https://latinlawyer.com/article/1170930/acon-and-humus-capital-in-pharma-acquisition